Evidence map›Paper›PMID 32071317›Full record

ArticleNature communications2020

A lncRNA-SWI/SNF complex crosstalk controls transcriptional activation at specific promoter regions.

Elena Grossi, Ivan Raimondi, Enrique Goñi, Jovanna González, Francesco P Marchese, Vicente Chapaprieta, José I Martín-Subero, Shuling Guo, Maite Huarte

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 114 citations in OpenAlex.

  1. Article
  2. Direct roles of long non-coding RNAs in transcription activation.Nature structural & molecular biology · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Genetic and Epigenetic Interactions Involved in Senescence of Stem Cells.International journal of molecular sciences · 2024
    Review
  20. Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Elena GrossiDepartment of Gene Therapy and Regulation of Gene Expression, Center for Applied Medical Research, University of Navarra, Pamplona, 31008, Spain.ORCID http://orcid.org/0000-0003-3938-5000
Ivan RaimondiDepartment of Gene Therapy and Regulation of Gene Expression, Center for Applied Medical Research, University of Navarra, Pamplona, 31008, Spain.
Enrique GoñiDepartment of Gene Therapy and Regulation of Gene Expression, Center for Applied Medical Research, University of Navarra, Pamplona, 31008, Spain.
Jovanna GonzálezDepartment of Gene Therapy and Regulation of Gene Expression, Center for Applied Medical Research, University of Navarra, Pamplona, 31008, Spain.
Francesco P MarcheseDepartment of Gene Therapy and Regulation of Gene Expression, Center for Applied Medical Research, University of Navarra, Pamplona, 31008, Spain.
Vicente ChapaprietaDepartament de Fonaments Clinics, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain.ORCID http://orcid.org/0000-0002-4910-5394
José I Martín-SuberoDepartament de Fonaments Clinics, Facultat de Medicina, Universitat de Barcelona, Barcelona, Spain.
Shuling GuoDepartment of Antisense Drug Discovery and Clinical Development, Ionis Pharmaceuticals, Carlsbad, CA, USA.
Maite HuarteDepartment of Gene Therapy and Regulation of Gene Expression, Center for Applied Medical Research, University of Navarra, Pamplona, 31008, Spain. maitehuarte@unav.es.ORCID http://orcid.org/0000-0003-3753-6493
Navarre Institute of Health Research · ESInstitució Catalana de Recerca i Estudis Avançats · ESIonis Pharmaceuticals (United States) · USUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

LncRNAs have been shown to be direct players in chromatin regulation, but little is known about their role at active genomic loci. We investigate the role of lncRNAs in gene activation by profiling the RNA interactome of SMARCB1-containing SWI/SNF complexes in proliferating and senescent conditions. The isolation of SMARCB1-associated transcripts, together with chromatin profiling, shows prevalent association to active regions where SMARCB1 differentially binds locally transcribed RNAs. We identify SWINGN, a lncRNA interacting with SMARCB1 exclusively in proliferating conditions, exerting a pro-oncogenic role in some tumor types. SWINGN is transcribed from an enhancer and modulates the activation of GAS6 oncogene as part of a topologically organized region, as well as a larger network of pro-oncogenic genes by favoring SMARCB1 binding. Our results indicate that SWINGN influences the ability of the SWI/SNF complexes to drive epigenetic activation of specific promoters, suggesting a SWI/SNF-RNA cooperation to achieve optimal transcriptional activation.

Indexed as

Gene Expression Regulation, NeoplasticAnimalsApoptosisCarcinogenesisCell ProliferationDatasets as TopicFemaleGene Regulatory NetworksGrowth Arrest-Specific Protein 6HCT116 CellsHEK293 CellsHumansIntercellular Signaling Peptides and ProteinsMiceNeoplasmsPromoter Regions, GeneticGrowth Arrest-Specific Protein 6Intercellular Signaling Peptides and ProteinsRNA, Long NoncodingRNA, Small InterferingSMARCB1 ProteinSMARCB1 protein, human

Identifiers

PMID32071317
PMCPMC7028943
OpenAlexW3008948271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.